Ralf Gutzmer Selected Research

Ralf Gutzmer Research Topics

Disease

110	Melanoma (Melanoma, Malignant) 04/2022 - 04/2007
53	Neoplasms (Cancer) 01/2022 - 07/2004
21	Neoplasm Metastasis (Metastasis) 01/2022 - 04/2008
17	Skin Neoplasms (Skin Cancer) 04/2022 - 06/2014
11	Basal Cell Carcinoma (Rodent Ulcer) 04/2022 - 06/2014
11	Atopic Dermatitis (Atopic Eczema) 10/2021 - 03/2002
11	Psoriasis (Pustulosis Palmaris et Plantaris) 09/2021 - 12/2003
11	Inflammation (Inflammations) 12/2020 - 03/2002
10	Skin Diseases (Skin Disease) 01/2020 - 06/2005
9	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2021 - 10/2012
6	Exanthema (Rash) 01/2021 - 01/2010
6	Neutropenia 01/2021 - 07/2012
5	Brain Neoplasms (Brain Tumor) 01/2022 - 01/2018
5	Disease Progression 01/2020 - 08/2007
4	Uveal melanoma 01/2022 - 07/2017
4	Fever (Fevers) 01/2020 - 07/2012
4	Arthralgia (Joint Pain) 01/2020 - 07/2012
4	Autoimmune Diseases (Autoimmune Disease) 11/2019 - 07/2006
4	Necrosis 01/2011 - 12/2003
3	Fatigue 10/2021 - 07/2012
3	Nausea 10/2021 - 07/2012
3	Infections 01/2021 - 07/2006
3	Lymphatic Metastasis 11/2020 - 01/2016
3	Colitis 11/2019 - 01/2017
3	Myositis (Idiopathic Inflammatory Myopathies) 01/2019 - 05/2018
3	Hypertension (High Blood Pressure) 10/2018 - 01/2017
3	Pruritus (Itching) 01/2014 - 03/2009
2	Merkel Cell Carcinoma 01/2022 - 10/2020
2	COVID-19 01/2022 - 01/2021
2	Alopecia (Baldness) 10/2021 - 10/2008
2	Carcinogenesis 10/2021 - 06/2010
2	Lymphoma (Lymphomas) 10/2021 - 03/2007
2	Pancreatitis 01/2021 - 01/2018
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 10/2020
2	Sarcoma (Soft Tissue Sarcoma) 01/2019 - 03/2002
2	Myalgia 10/2018 - 01/2018
2	Drug-Related Side Effects and Adverse Reactions 06/2017 - 04/2016
2	Vomiting 07/2013 - 07/2012
2	Dermatitis 07/2013 - 01/2009
2	Pigmented Nevus (Melanocytic Nevus) 10/2012 - 06/2010
2	Eczema 07/2012 - 06/2005

Drug/Important Bio-Agent (IBA)

30	Immune Checkpoint InhibitorsIBA 01/2022 - 04/2015
23	IpilimumabIBA 01/2022 - 01/2013
17	NivolumabIBA 01/2022 - 04/2015
17	Histamine (Histamine Dihydrochloride)FDA Link 10/2021 - 03/2002
16	pembrolizumabIBA 04/2022 - 01/2016
16	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 05/2015
12	VemurafenibIBA 01/2021 - 10/2012
9	AntibodiesIBA 01/2022 - 01/2016
7	binimetinibIBA 01/2022 - 01/2017
7	encorafenibIBA 01/2022 - 01/2018
6	HhAntag691IBA 04/2022 - 05/2014
6	sonidegibIBA 11/2021 - 06/2015
6	Dacarbazine (DIC)FDA LinkGeneric 01/2020 - 10/2009
6	Histamine H4 ReceptorsIBA 01/2020 - 01/2009
6	InterferonsIBA 05/2018 - 06/2005
5	Biomarkers (Surrogate Marker)IBA 04/2022 - 11/2016
5	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022 - 07/2017
5	Monoclonal AntibodiesIBA 01/2020 - 09/2014
5	Proteins (Proteins, Gene)FDA Link 01/2020 - 10/2006
5	CytokinesIBA 02/2012 - 12/2003
4	ChemokinesIBA 10/2021 - 01/2015
4	Pharmaceutical PreparationsIBA 01/2020 - 01/2013
4	dabrafenibIBA 01/2020 - 07/2012
4	Histamine Receptors (Histamine Receptor)IBA 01/2020 - 01/2011
4	Programmed Cell Death 1 ReceptorIBA 01/2020 - 01/2017
4	Creatine Kinase (Creatine Phosphokinase)IBA 01/2019 - 01/2017
4	Interferon alpha-2 (Roferon-A)FDA Link 05/2018 - 01/2013
3	Sirolimus (Rapamycin)FDA Link 10/2021 - 06/2014
3	AntigensIBA 01/2021 - 01/2011
3	cemiplimabIBA 01/2021 - 01/2020
3	talimogene laherparepvecIBA 01/2021 - 12/2018
3	Lipase (Acid Lipase)FDA Link 01/2021 - 04/2015
3	Alanine Transaminase (SGPT)IBA 01/2020 - 04/2015
3	Mitogen-Activated Protein KinasesIBA 05/2019 - 01/2019
3	ParaffinIBA 11/2015 - 06/2010
3	Formaldehyde (Formol)FDA Link 11/2015 - 06/2010
3	InterleukinsIBA 02/2012 - 06/2005
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2005 - 12/2003
2	Rituximab (Mabthera)FDA Link 01/2022 - 01/2021
2	MTOR InhibitorsIBA 10/2021 - 06/2014
2	mogamulizumabIBA 09/2021 - 01/2021
2	cyclopropapyrroloindoleIBA 01/2021 - 10/2020
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 10/2020
2	cobimetinibIBA 01/2021 - 01/2020
2	Imiquimod (Aldara)FDA LinkGeneric 12/2020 - 01/2002
2	B7-H1 AntigenIBA 11/2020 - 11/2018
2	AutoantibodiesIBA 01/2020 - 12/2007
2	DNA (Deoxyribonucleic Acid)IBA 12/2016 - 03/2002
2	1- ((5- chloro- 1H- indol- 2- yl)carbonyl)- 4- methylpiperazineIBA 12/2013 - 01/2009
2	Messenger RNA (mRNA)IBA 12/2013 - 03/2009
2	Sorafenib (BAY 43-9006)FDA Link 09/2013 - 01/2010

Therapy/Procedure

81	Therapeutics 04/2022 - 07/2006
12	Immunotherapy 01/2022 - 02/2012
10	Radiotherapy 01/2022 - 05/2014
9	Drug Therapy (Chemotherapy) 01/2022 - 03/2007
5	Lymph Node Excision (Lymph Node Dissection) 01/2022 - 08/2013
3	Aftercare (After-Treatment) 06/2021 - 01/2017
2	Drug Tapering 01/2021 - 01/2010
2	Organ Transplantation 01/2019 - 11/2017